Permira selling Pharmaq

We have together with Skadden, Arps, Slate, Meagher & Flom assisted the international private equity fund Permira in connection with their sale of Pharmaq,, a leading manufacturer of vaccines for aquaculture.

Pharmaq was sold for MUSD 765 on a debt free basis. The WR team was led by Arne Didrik Kjørnæs.

Press release